IMCD appoints Angelique Kruif as Global People Director

Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations

Evonik bets €80 million on biotech expansion to power next-gen pharma growth

The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push

The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform

Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies

Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research

Zyax Chem takes 26% stake in Gaymed Labs

Targets high-growth eye care expansion push

Merck unveils bio-based HPLC solvents slashing CO2 emissions by up to 29%

Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials

AWS unveils Amazon Bio Discovery to accelerate drug design with AI

Galderma rolls out next-generation regenerating skin nectar

Bayer flags major Phase III results for stroke prevention drug asundexian

The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy

OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants

New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences